W. Va. Code R. § 64-7-10 - Other Reportable Events: Bioterrorism Response
Current through Register Vol. XXXVIII, No. 51, December 23, 2021
10.1. All health care providers, health care
facilities, animal health care providers, laboratories and law enforcement
personnel shall report suspected or confirmed disease due to a bioterrorism
agent immediately by telephone with follow up by other rapid means of
notification to the local health department in the jurisdiction where the
bioterrorist event is identified.
10.2. Suspect disease due to bioterrorism
agents may be identified by the following epidemiological findings:
10.2.a. Unusual temporal or geographic
clustering of illness. This might include persons who attended the same public
event or gathering, or patients presenting with clinical signs and symptoms
that suggest an infectious disease outbreak. More than two persons presenting
with an unexplained febrile illness associated with sepsis, pneumonia,
respiratory failure, rash or a botulism-like syndrome with flaccid paralysis,
especially if occurring in otherwise healthy persons;
10.2.b. An unusual age distribution for
common diseases, such as an increase in what appears to be a chickenpox like
illness among adult patients, but which might be smallpox;
10.2.c. A large number of cases of acute
flaccid paralysis with prominent bulbar palsies, suggestive of a release of
botulinum toxin;
10.2.d. A
laboratory finding characteristic of one of the known bioterrorism
agents;
10.2.e. An unusually high
number of laboratory samples, particularly from the same biologic medium, such
as blood or stool cultures;
10.2.f.
Unusual requests for testing or culturing; or
10.2.g. Any other unusual medical, laboratory
or epidemiological findings not consistent with known patterns of transmission
of naturally-occurring infectious agents.
10.3. Bioterrorism agents may include, but
are not limited to:
10.3.a. Anthrax
(Bacillis anthracis);
10.3.b. Botulism (Clostridium
botulinum toxin);
10.3.c.
Brucellosis (Brucella species);
10.3.d. Epsilon toxin of Clostridium
perfringens;
10.3.e. Food
safety threats (e.g., Salmonella species, Escherichia
coli O157:H7, Shigella);
10.3.f. Glanders (Burkholderia
mallei);
10.3.g.
Melioidosis (Burkholderia pseudomallei);
10.3.h. Plague (Yersinia
pestis);
10.3.i.
Psittacosis (Chlamydia psittaci);
10.3.j. Q fever (Coxiella
burnetii);
10.3.k. Ricin
toxin from Riccinus communis (castor beans);
10.3.l. Smallpox (variola major);
10.3.m. Staphylococcal enterotoxin
B;
10.3.n. Tularemia
(Francisella tularensis);
10.3.o. Typhus fever (Rickettsia
prowazekii);
10.3.p. Viral
encephalitis (alphaviruses [e.g., Venezuelan equine encephalitis, eastern
equine encephalitis, western equine encephalitis]);
10.3.q. Viral hemorhagic fevers (filoviruses
[e.g., Ebola, Marburg] and arenaviruses [e.g., Lassa, Machupo]); and
10.3.r. Water safety threats, such as
Vibrio cholerae, Cryptosporidium parvum.
10.4. In the event of a suspected or
confirmed bioterrorist event, the Commissioner may designate a disease or
condition as immediately reportable by direct notification of local health
departments and/or health care providers by any rapid means available. In that
situation, the Commissioner may request the reporting of cases by phone or by
filing an electronic report with WVEDSS.
10.5. The local health officer, on
notification of a suspected or confirmed bioterrorist event shall immediately
notify the Bureau by phone 1(800) 423-1271 or (304) 558-5358. The local health
officer shall also report cases by using WVEDSS.
10.6. As appropriate, the local health
officer shall collaborate in an investigation of the bioterrorist event with:
10.6.a. Other local health officers if cases
from other local health jurisdictions are identified;
10.6.b. Public health officials from other
states if cases from those states are identified;
10.6.c. The department;
10.6.d. Federal public health officials;
and
10.6.e. Law enforcement
personnel.
10.7. The
local health officer shall collaborate in an epidemiological investigation of
the bioterrorist event, usually to include a complete outbreak investigation as
described in section seven (7) of this rule.
10.8. The Commissioner shall collaborate with
the Federal Bureau of Investigation and other federal, state and local law
enforcement, emergency responders and other public safety representatives to
develop and use a protocol for sharing information on an investigation.
10.8.a. Information may only be shared if the
Commissioner determines that sharing such information is critical to protecting
the public's health.
10.8.b. Any
information shared shall be protected from further disclosure in a manner
consistent with state and federal law and regulations and in accordance with
the protocol agreed upon by all parties.
Notes
The following state regulations pages link to this page.
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.